Therabron gets $6.75M for drug that helps premature babies breathe easy
Preterm infants have poorly formed lungs, and struggle to breathe. Maryland startup Therabron Therapeutics just raised $6.75 million for its Phase 2 drug that helps regulate breathing in infants with respiratory difficulties.